Page last updated: 2024-12-06
asocainol
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
asocainol: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 71161 |
| CHEMBL ID | 2104050 |
| SCHEMBL ID | 1815839 |
| MeSH ID | M0124969 |
Synonyms (24)
| Synonym |
|---|
| (+/-)-asocainol |
| asocainol |
| FT-0662306 |
| 77400-65-8 |
| goe 3764-a |
| unii-j40338okkt |
| asocainol [inn] |
| (+-)-6,7,8,9-tetrahydro-2,12-dimethoxy-7-methyl-6-phenethyl-5h-dibenz(d,f)azonin-1-ol |
| asocainolum [inn-latin] |
| j40338okkt , |
| asocainolum |
| CHEMBL2104050 |
| 6,7,8,9-tetrahydro-2,12-dimethoxy-7-methyl-6-(2-phenylethyl)-5h-dibenz[d,f]azonin-1-ol |
| (+/-)-6,7,8,9-tetrahydro-2,12-dimethoxy-7-methyl-6-phenethyl-5h-dibenz(d,f)azonin-1-ol |
| SCHEMBL1815839 |
| 95263-30-2 |
| Q4807483 |
| go 4704; goe 4704 |
| A936159 |
| 2,12-dimethoxy-7-methyl-6-(phenethyl)-6,7,8,9-tetrahydro-5h-dibenzo[d,f]azonin-1-ol |
| 4,16-dimethoxy-10-methyl-9-(2-phenylethyl)-10-azatricyclo[11.4.0.02,7]heptadeca-1(13),2(7),3,5,14,16-hexaen-3-ol |
| DTXSID90868434 |
| 2,12-dimethoxy-7-methyl-6-(2-phenylethyl)-6,7,8,9-tetrahydro-5h-dibenzo[d,f]azonin-1-ol |
| (-)-6,7,8,9-tetrahydro-2,12-dimethoxy-7-methyl-6-phenethyl-5h-dibenz[d,f]azonin-1-ol |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.46
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.46) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||